Last updated: June 4, 2026
ZELVYSIA Suppliers: Who Manufactures and Supplies the Drug, Active Ingredient, and Finished Product
ZELVYSIA is a branded pharmaceutical product. Supplier mapping depends on the drug’s listed manufacturer(s) for the commercial finished dosage form and, separately, any contract manufacturing for drug substance and drug product. No complete, citable supplier list can be produced from the information provided.
Who are the suppliers and manufacturers for ZELVYSIA finished product (drug product)
Answer: Not determinable from the provided inputs.
What to look for in the supply chain
- FDA labeling “Manufactured for” / “Distributed by”
- NDC labeler name and corresponding manufacturer for the marketed strength(s)
- CDER drug application label history tied to the approved NDA/BLA and dosage form
Which supplier categories matter
- Finished dose drug product manufacturer
- Labeler/distributor (commercial supply)
- Contract manufacturing organizations (CMOs) if disclosed in labeling
Who supplies ZELVYSIA drug substance (API) and intermediates
Answer: Not determinable from the provided inputs.
Typical API supply routes
- In-house synthesis at an approved API site
- CMO-supplied API with GMP drug substance registration
- Multiple source API qualification for commercial redundancy
What is the Orange Book listing status of ZELVYSIA suppliers
Answer: Not determinable from the provided inputs.
Orange Book fields that identify supply-relevant entities
- Listed drug entry and strengths
- Applicant/manufacturer on the listing
- Exclusivity status tied to the application and labeling
What companies supply ZELVYSIA to the US market
Answer: Not determinable from the provided inputs.
US market supply indicators
- Labeler name by NDC
- Manufacturer in prescribing information
- Wholesale distributor listings derived from labeler/manufacturer
Which CMOs manufacture ZELVYSIA under contract
Answer: Not determinable from the provided inputs.
How contract manufacturing is evidenced
- “Manufactured by” language pointing to a CMO
- Site-level GMP compliance records linked to the application
- Supplier disclosure in labeling or submission exhibits
How do ZELVYSIA supplier risks affect continuity of supply
Answer: Not determinable from the provided inputs.
Risk categories
- Single-site dependency for sterility or specialized manufacturing steps (if applicable)
- Dependency on one upstream API intermediate
- Lead-time fragility in sourcing schedules
How does ZELVYSIA’s supplier chain compare with competing brands
Answer: Not determinable from the provided inputs.
Relevant comparators
- Same therapeutic class branded products with similar dosage form
- Shared CMOs across portfolios (if identifiable)
Key Takeaways
- A supplier list for ZELVYSIA cannot be compiled from the information provided.
- Supplier identification requires drug labeler/manufacturer and NDC-linked manufacturer data, typically sourced from FDA labeling/Orange Book and NDC labeler records.
FAQs
- How can I identify the ZELVYSIA drug product manufacturer from the label?
- Does ZELVYSIA have multiple NDC labelers or manufacturing sites?
- How do I determine whether ZELVYSIA API is outsourced to a CMO?
- Where do I find ZELVYSIA manufacturing sites tied to FDA submissions?
- What records show contract manufacturing for ZELVYSIA drug product?
References
- FDA Orange Book database.
- FDA prescribing information and labeling for ZELVYSIA.
- FDA NDC Directory (labeler and manufacturer listings).
